TGRP — Nanopharmaceutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $104.40m
- $103.36m
- $1.48m
Annual balance sheet for Nanopharmaceutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 0.352 | 0.1 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.187 | 0.091 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Current Assets | 1.06 | 0.408 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.328 | 0.258 |
| Total Assets | 1.39 | 0.666 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 8.32 | 9.62 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Liabilities | 8.13 | 8.74 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -6.74 | -8.08 |
| Total Liabilities & Shareholders' Equity | 1.39 | 0.666 |
| Total Common Shares Outstanding |